163 filings
8-K
TTOO
T2 Biosystems Inc
7 May 24
Other Events
4:48pm
8-K
TTOO
T2 Biosystems Inc
6 May 24
T2 Biosystems Announces First Quarter 2024 Financial Results
5:24pm
8-K
TTOO
T2 Biosystems Inc
18 Apr 24
Entry into a Material Definitive Agreement
4:12pm
8-K
TTOO
T2 Biosystems Inc
12 Apr 24
Submission of Matters to a Vote of Security Holders
4:47pm
8-K
TTOO
T2 Biosystems Inc
28 Mar 24
Regulation FD Disclosure
4:31pm
8-K
ncsr0mes8j8ms 7f5fc3
20 Mar 24
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
9:17am
8-K
13t nmv3b6jg
18 Mar 24
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
9:06am
8-K
0yqboa6ea swymth
12 Mar 24
Other Events
9:00am
8-K
cvto2wh
16 Feb 24
Results of Operations and Financial Condition
5:00pm
8-K
b83agx7sksr j1y9uqm
15 Feb 24
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
4:47pm
8-K
y3wso2k78j5y xmn
5 Jan 24
Departure of Directors or Certain Officers
4:00pm
8-K/A
m47n7i 6p3a333knl
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
lg0z0m0h
1 Nov 23
Other Events
9:08am
8-K
3vdur3jxzl0142mnt
25 Oct 23
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
9:02am
8-K
q5w9bae x25hdbh
23 Oct 23
Entry into a Material Definitive Agreement
9:00am
8-K
s04wq
17 Oct 23
Results of Operations and Financial Condition
4:31pm
8-K
wnh4y9jwwbs0 n4t
12 Oct 23
T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
4:32pm
8-K
oz9jkjvamzy 633i0
12 Oct 23
Material Modifications to Rights of Security Holders
4:01pm
8-K
30iwj2 5juh2
18 Sep 23
Departure of Directors or Certain Officers
5:03pm
8-K
ryedaalis j8nzv1jzu0
11 Aug 23
T2 Biosystems Announces Second Quarter 2023 Financial Results
4:00pm